SCHEMBL5236476

SCHEMBL5236476

CC(=O)Cc1c(Br)ccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 4/20 0.47
GAA P10253 3/20 0.47
HSD17B10 Q99714 2/20 0.47
HPGD P15428 2/20 0.47
GLA P06280 1/20 0.47
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPT P10636 5/20 0.41
RXFP1 Q9HBX9 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
NCEH1 Q6PIU2 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1913995 0.92 ALDH1A1 (0.45) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL3586863 0.84 KDM4E (0.67) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL5237285 0.83 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL2369777 0.83 KDM4E (0.47) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL10678775 0.82 EGFR (0.47) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL5233007 0.81 CYP1A2 (0.42) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL6622985 0.81 KDM4E (0.72) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL6179565 0.81 ALDH1A1 (0.49) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL8474945 0.76 POLB (0.47) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL7783948 0.76 NCEH1 (0.45) ALDH1A1KDM4EGAAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110903158-A Organic luminescent material containing anthracene derivative, preparation method thereof and electroluminescent device 上海和辉光电有限公司 2020-03-24 CN disclosed
EP-1851232-A2 DIHYDROIMIDAZOTHIAZOLE DERIVATIVES Prosidion Limited (GB) 2007-11-07 EP disclosed
WO-2006085118-A2 DIHYDROIMIDAZOTHIAZOLE DERIVATIVES PROSIDION LIMITED (GB) 2006-08-17 WO disclosed
EP-1648876-A1 5-HT SB 2B /SB RECEPTOR ANTAGONISTS Pharmagene Laboratories Ltd (GB) 2006-04-26 EP disclosed
WO-2005012263-A1 5-HT2B RECEPTOR ANTAGONISTS PHARMAGENE LABORATORIES LIMITED (GB) 2005-02-10 WO disclosed
EP-1474140-A1 2-OXAZOLAMINES AND THEIR USE AS 5-HT2B RECEPTOR ANTAGONISTS Pharmagene Laboratories Ltd (GB) 2004-11-10 EP disclosed
WO-2003068226-A1 2-OXAZOLAMINES AND THEIR USE AS 5-HT2B RECEPTOR ANTAGONISTS PHARMAGENE LABORATORIES LIMITED (GB) 2003-08-21 WO disclosed